CDY
Click for more information
1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-672

  1. David Bo$$
    356 Posts.
    lightbulb Created with Sketch. 56
    clock Created with Sketch.
    09/07/18
    19:44
    Post #: 34236762
    Can anyone explain what the difference is between the 4c cash flow report, sales revenue and why the two don't reconcile at the end of quarter and reasons why this might be?

    Should the cash flow report be used as an indicator of trend sales growth or is sales revenue a better indicator?
    Last edited by David Bo$$: 09/07/18
    CDY Price at posting: 43.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

USQ Expanded deep drilling gold program unveiled for Leonora flagship project
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
NEWS OVD027 intercepts massive sulphide creating continued optimism
right-arrow Created with Sketch.
NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
NEWS Updated resource estimates soar for the Pepper Gold Deposit in Western Australia
right-arrow Created with Sketch.
RMS Flicka Lake Project enters promising new era as highly encouraging results found
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.